Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

KERNX Health vs telos rx

By GLP-1 ScorecardUpdated

KERNX HealthFactor scores not reassessed.
Site position #97

Lower score

telos rxFactor scores not reassessed.
Site position #13

Higher score

Score comparison

telos rx has the higher recorded score — 85.4/100 to 71.8/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.

Before you choose

Before comparing the headline prices, the KERNX Health review and the telos rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, KERNX Health vs Trimi and Kina vs telos rx compare each of them with another graded program, and the list of alternatives to KERNX Health ranks the programs closest to KERNX Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the bmiMD review covers one graded close to these two, at 79.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuetelos rx +13
74
87
Dose & formulationtelos rx +22
68
90
Clinical oversighttelos rx +2
82
84
Labs & monitoringtelos rx +25
55
80
Fulfillmenttelos rx +19
68
87
Contract termsKERNX Health +6
86
80
KERNX Health · top bartelos rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricKERNX Healthtelos rx
WeighScore71.8/10085.4/100
GradeCB
Site position#97#13
SemaglutideAdvertised $209 per four-week supply (compounded injection); oral $279Advertised from $99/month injectable; plan-dependent; selected bill unverified.
TirzepatideAdvertised $299 per four-week supply (compounded injection)Advertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified.
CoverageProvider network advertises all 50 states; confirm treatment availabilityAdvertises all 50 states; pharmacy and formulation availability varies.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
KERNX Health

Site position #97 · C

Factor scores not reassessed.

Strengths

  • Advertised pricing separates single-supply rates from prepaid totals
  • Published terms include coaching, shipping and provider-ordered testing in month two

What to consider

  • Prepaid terms can renew automatically for the selected period
  • Later testing costs and the assigned pharmacy need confirmation
telos rx

Site position #13 · B

Factor scores not reassessed.

Strengths

  • Names its care organization and pharmacy partners
  • Oral and injectable compounded options

What to consider

  • Early cancellation can reprice supplied months
  • Entity, denial-refund and lab terms conflict
  • Current oral invoice and renewal price unverified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard